Ahmedabad-based Corona Remedies has entered into an agreement with the Indian subsidiary of Switzerland-based global biopharmaceuticals company Ferring Pharmaceuticals, to commercialise unique and innovative products in the field of maternal health & urology.

The collaboration between Corona and Ferring will cater to patients across India with innovative products including a few global brands to address the unmet therapeutic needs in maternal health and urology.

Corona is among the leaders in women's healthcare and has a strong presence in various therapies such as anti-hypertensive, diabetes, neuropathy, hormones, pain management, dermatology, bone health, anti-ulcerant, & nutritional supplements. 

Ferring’s maternal health products are acknowledged in many countries and backed by clinical studies with proven efficacy and safety. The urology products are formulated in an innovative dosage form based on Ferring’s new proprietary technology platform that will offer great convenience to patients with over active bladder and erectile dysfunction.

All the products are unique in their class, having differentiated formulations and drug delivery systems that offer therapeutic advantages along with patient compliance and convenience. The estimated market size for the said products collectively is Rs 778.30 crore & growing by 27%.

The novel products will be distributed by 1500+ authorised stockiests of Corona Remedies across the country.